NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister|Nature|2021Cited by 1.2k
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signallingElena Kotsiliti, Nisar P. Malek, Olivier Govaere et al.|Journal of Hepatology|2023Cited by 92